Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Krzysztof Domka
Observed name:
K. Domka
Institutions:
Medical University of Warsaw,
Mossakowski Medical Research Institute, Polish Academy of Sciences,
Polish Academy of Sciences
Observed institutions:
Medical University of Warsaw,
Mossakowski Medical Research Institute, Polish Academy of Sciences,
Polish Academy of Sciences
ORCID:
0000-0002-2856-6968
Observed ORCID:
0000-0002-2856-6968
OpenAlex ID:
A5027945148
Works
12
Awards
1
Mechanisms of Immune Evasion in Acute Lymphoblastic Leukemia
2021
·
Agata Pastorczak
, Krzysztof Domka
, et al.
·
Cancers
·
83
PDF
Advancements in cancer immunotherapies targeting CD20: from pioneering monoclonal antibodies to chimeric antigen receptor-modified T cells
2024
·
Agnieszka Dabkowska
, Krzysztof Domka
, et al.
·
Frontiers in Immunology
·
61
PDF
Potent, p53-independent induction of NOXA sensitizes MLL-rearranged B-cell acute lymphoblastic leukemia cells to venetoclax
2022
·
Klaudyna Fidyt
, Agata Pastorczak
, et al.
·
Oncogene
·
21
PDF
cROSsing the Line: Between Beneficial and Harmful Effects of Reactive Oxygen Species in B-Cell Malignancies
2020
·
Krzysztof Domka
, Agnieszka Goral
, et al.
·
Frontiers in Immunology
·
21
PDF
Asciminib stands out as the superior tyrosine kinase inhibitor to combine with anti-CD20 monoclonal antibodies for the treatment of CD20+ Philadelphia-positive B-cell precursor acute lymphoblastic leukemia in preclinical models
2024
·
Krzysztof Domka
, Agnieszka Dąbkowska
, et al.
·
Haematologica
·
5
Abstract 3324: Optimizing the therapeutic potential of tyrosine kinase inhibitors in chemo-immunotherapy of B-cell acute lymphoblastic leukemia involving rituximab
2022
·
Krzysztof Domka
, Martyna Poprzeczko
, et al.
·
Cancer Research
·
1
682 Pharmacologic induction of B-cell maturation sensitizes B-cell precursor acute lymphoblastic leukemia to anti-CD20 immunotherapy
2026
·
Malgorzata Firczuk
, Agnieszka Dabkowska
, et al.
·
Journal for ImmunoTherapy of Cancer
PDF
3061 – Mtorc1 Inhibition Enhances Anti-cd20 Immunotherapy in B-all Via the Akt-foxo1 Axis
2026
·
Agnieszka Dabkowska
, Martyna Janowska
, et al.
·
Experimental Hematology
mTORC1 inhibition upregulates CD20 and enhances anti-CD20 antibody efficacy in B-cell precursor acute lymphoblastic leukemia
2026
·
Agnieszka Dąbkowska
, Martyna Janowska
, et al.
·
Leukemia
PDF
Successful treatment of central nervous system relapse of primary mediastinal large B-cell lymphoma with the R-MIV regimen: a case report
2026
·
Marcin Jasiński
, Krzysztof Domka
, et al.
·
Folia Neuropathologica
PDF
P339: Boosting the Efficacy of Cd20-targeting Immunotherapy in B Cell Acute Lymphoblastic Leukemia
2022
·
M. Poprzeczko
, K. Domka
, et al.
·
HemaSphere
Pharmacological Induction of NOXA Sensitizes High-Risk B Cell Acute Lymphoblastic Leukemia Cells to Venetoclax
2020
·
Klaudyna Fidyt
, Julia Cyran
, et al.
·
Blood
Show more works
View as search
Works count:
12
Citation count:
192
H-index:
5
I10-index:
4
Year
Topic
Type